Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radioimmunoassay for plasma thromboxane B2

D S McCann, J Tokarsky, R P Sorkin

    Clinical Chemistry
    |August 1, 1981
    PubMed
    Summary

    This study presents a new radioimmunoassay for measuring plasma thromboxane B2, a key indicator of platelet activity in cardiovascular disease. The assay is simple, sensitive, and specific for assessing acute platelet aggregation events.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Preparation and characterization of photoactive composite kaolinite/TiO(2).

    Journal of hazardous materials·2011
    Same author

    Effects of cocaine and d-amphetamine on sustained and selective attention in rats.

    Pharmacology, biochemistry, and behavior·1989
    Same author

    Symptoms of insulin-induced hypoglycemia in normal subjects.

    Journal of psychosomatic research·1988
    Same author

    Endocrine and physiological changes during "spontaneous" panic attacks.

    Psychoneuroendocrinology·1987
    Same author

    Cholecystographic agents and sulfobromophthalein inhibit the binding of L-thyroxine to plasma membranes of rat hepatocytes.

    Endocrinology·1986
    Same author

    Anomalous pulmonary venous connection. Medical therapy.

    Chest·1986

    Area of Science:

    • Biochemistry
    • Cardiovascular Medicine
    • Analytical Chemistry

    Background:

    • Platelet activity is crucial in the acute phase of atherosclerotic cardiovascular disease.
    • A reliable assay for plasma thromboxane B2 (a platelet-specific metabolite) is needed to assess platelet activity.
    • Thromboxane B2 is a prostaglandin metabolite unique to platelets.

    Purpose of the Study:

    • To develop and validate a radioimmunoassay for plasma thromboxane B2.
    • To assess acute events involving platelet aggregation using the developed assay.
    • To evaluate the assay's simplicity, reproducibility, sensitivity, and specificity.

    Main Methods:

    • A radioimmunoassay using nonequilibrium incubation and solid-phase second-antibody separation.
    • No prior purification of plasma samples was required.
    • Measurement of plasma thromboxane B2 concentrations in normal subjects and after aspirin ingestion.

    Main Results:

    • The assay is simple, reproducible, sensitive, and specific.
    • Normal subjects averaged 39.0 ng/L plasma thromboxane B2.
    • Plasma thromboxane B2 concentrations differed significantly before and after aspirin ingestion (p < 0.025).

    Conclusions:

    • The developed radioimmunoassay effectively measures plasma thromboxane B2.
    • This assay can be utilized to reflect acute events involving platelet aggregation.
    • The assay provides a valuable tool for studying platelet activity in cardiovascular disease.

    Related Experiment Videos